Halaven Patient Registry (Metastatic Breast Cancer, MBC)
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Advanced Breast Cancer
Interventions: DRUG: Eribulin Mesylate
Sponsor: Chang Gung Memorial Hospital
Collaborators: Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)|Eisai Co., Ltd.